表紙:口腔内崩壊錠の世界市場:考察と予測 (2029年まで)
市場調査レポート
商品コード
1187326

口腔内崩壊錠の世界市場:考察と予測 (2029年まで)

Global Orally Disintegrating Tablet Market Insights, Forecast to 2029

出版日: | 発行: QYResearch | ページ情報: 英文 94 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
口腔内崩壊錠の世界市場:考察と予測 (2029年まで)
出版日: 2023年01月19日
発行: QYResearch
ページ情報: 英文 94 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の口腔内崩壊錠の市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2018年~2029年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 調査概要

  • 調査範囲
  • 種類別の市場分析
    • 市場規模・成長率:種類別 (2018年・2022年・2029年)
    • 抗精神病薬
    • 抗てんかん薬
    • その他
  • 用途別の市場
    • 市場シェア:用途別 (2018年・2022年・2029年)
    • 病院
    • 小売薬局
    • その他
  • 分析対象
  • 分析期間

第2章 世界の成長動向

  • 世界の口腔内崩壊錠市場の展望 (2018年~2029年)
  • 口腔内崩壊錠の成長動向:地域別
  • 口腔内崩壊錠の市場力学

第3章 主要企業別の競合情勢

  • 主要口腔内崩壊錠企業の収益
  • 市場シェア:企業の種類別 (ティア1、ティア2、ティア3)
  • 分析対象企業:口腔内崩壊錠の収益別のランキング (2021年・2022年・2023年)
  • 世界の口腔内崩壊錠市場の集中度
  • 口腔内崩壊錠の主要企業:本社・提供エリア
  • 口腔内崩壊錠の主要企業:製品とその用途
  • 口腔内崩壊錠市場への参入時期
  • 企業合併・買収 (M&A)、拡張計画

第4章 口腔内崩壊錠:種類別の内訳データ

  • 過去の市場規模:種類別 (2018年~2023年)
  • 市場規模の予測:種類別 (2024年~2029年)

第5章 口腔内崩壊錠:用途別の内訳データ

  • 過去の市場規模:用途別 (2018年~2023年)
  • 市場規模の予測:用途別 (2024年~2029年)

第6章 北米

  • 北米の口腔内崩壊錠の市場規模 (2018年~2029年)
  • 北米の口腔内崩壊錠の市場規模:種類別
  • 北米の口腔内崩壊錠の市場規模:用途別
  • 北米の口腔内崩壊錠の市場規模:国別
    • 米国
    • カナダ

第7章 欧州

  • 欧州の口腔内崩壊錠の市場規模 (2018年~2029年)
  • 欧州の口腔内崩壊錠の市場規模:種類別
  • 欧州の口腔内崩壊錠の市場規模:用途別
  • 欧州の口腔内崩壊錠の市場規模:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧諸国

第8章 中国

  • 中国の口腔内崩壊錠の市場規模 (2018年~2029年)
  • 中国の口腔内崩壊錠の市場規模:種類別
  • 中国の口腔内崩壊錠の市場規模:用途別

第9章 アジア (中国以外)

  • アジア (中国以外) の口腔内崩壊錠の市場規模 (2018年~2029年)
  • アジア (中国以外) の口腔内崩壊錠の市場規模:種類別
  • アジア (中国以外) の口腔内崩壊錠の市場規模:用途別
  • アジア (中国以外) の口腔内崩壊錠の市場規模:地域別
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中東・アフリカ・ラテンアメリカ

  • 中東・アフリカ・ラテンアメリカの口腔内崩壊錠の市場規模 (2018年~2029年)
  • 中東・アフリカ・ラテンアメリカの口腔内崩壊錠の市場規模:種類別
  • 中東・アフリカ・ラテンアメリカの口腔内崩壊錠の市場規模:用途別
  • 中東・アフリカ・ラテンアメリカの口腔内崩壊錠の市場規模:国別
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力会議 (GCC) 諸国

第11章 主要企業のプロファイル

  • Teva
  • Merck
  • Mylan
  • Pfizer
  • Johnson and Johnson
  • GSK
  • Otsuka
  • Eli Lilly and Company
  • AstraZeneca
  • Bristol-Myers Squibb
  • Conquer

第12章 アナリストの見解/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Orally Disintegrating Tablet Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Key Players of Anti-Psychotics Drug
  • Table 3. Key Players of Anti-Epileptics Drug
  • Table 4. Key Players of Others
  • Table 5. Global Orally Disintegrating Tablet Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Orally Disintegrating Tablet Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Orally Disintegrating Tablet Market Share by Region (2018-2023)
  • Table 9. Global Orally Disintegrating Tablet Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Orally Disintegrating Tablet Market Share by Region (2024-2029)
  • Table 11. Orally Disintegrating Tablet Market Trends
  • Table 12. Orally Disintegrating Tablet Market Drivers
  • Table 13. Orally Disintegrating Tablet Market Challenges
  • Table 14. Orally Disintegrating Tablet Market Restraints
  • Table 15. Global Orally Disintegrating Tablet Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global Orally Disintegrating Tablet Market Share by Players (2018-2023)
  • Table 17. Global Top Orally Disintegrating Tablet Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet as of 2021)
  • Table 18. Global Orally Disintegrating Tablet Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by Orally Disintegrating Tablet Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of Orally Disintegrating Tablet, Headquarters and Area Served
  • Table 21. Global Key Players of Orally Disintegrating Tablet, Product and Application
  • Table 22. Global Key Players of Orally Disintegrating Tablet, Date of Enter into This Industry
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Orally Disintegrating Tablet Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global Orally Disintegrating Tablet Revenue Market Share by Type (2018-2023)
  • Table 26. Global Orally Disintegrating Tablet Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global Orally Disintegrating Tablet Revenue Market Share by Type (2024-2029)
  • Table 28. Global Orally Disintegrating Tablet Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global Orally Disintegrating Tablet Revenue Market Share by Application (2018-2023)
  • Table 30. Global Orally Disintegrating Tablet Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global Orally Disintegrating Tablet Revenue Market Share by Application (2024-2029)
  • Table 32. North America Orally Disintegrating Tablet Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America Orally Disintegrating Tablet Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America Orally Disintegrating Tablet Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America Orally Disintegrating Tablet Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America Orally Disintegrating Tablet Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America Orally Disintegrating Tablet Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America Orally Disintegrating Tablet Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe Orally Disintegrating Tablet Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe Orally Disintegrating Tablet Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe Orally Disintegrating Tablet Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe Orally Disintegrating Tablet Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe Orally Disintegrating Tablet Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe Orally Disintegrating Tablet Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe Orally Disintegrating Tablet Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China Orally Disintegrating Tablet Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China Orally Disintegrating Tablet Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China Orally Disintegrating Tablet Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China Orally Disintegrating Tablet Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Orally Disintegrating Tablet Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia Orally Disintegrating Tablet Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia Orally Disintegrating Tablet Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia Orally Disintegrating Tablet Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia Orally Disintegrating Tablet Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia Orally Disintegrating Tablet Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia Orally Disintegrating Tablet Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Orally Disintegrating Tablet Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. Teva Company Details
  • Table 65. Teva Business Overview
  • Table 66. Teva Orally Disintegrating Tablet Product
  • Table 67. Teva Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 68. Teva Recent Development
  • Table 69. Merck Company Details
  • Table 70. Merck Business Overview
  • Table 71. Merck Orally Disintegrating Tablet Product
  • Table 72. Merck Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 73. Merck Recent Development
  • Table 74. Mylan Company Details
  • Table 75. Mylan Business Overview
  • Table 76. Mylan Orally Disintegrating Tablet Product
  • Table 77. Mylan Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 78. Mylan Recent Development
  • Table 79. Pfizer Company Details
  • Table 80. Pfizer Business Overview
  • Table 81. Pfizer Orally Disintegrating Tablet Product
  • Table 82. Pfizer Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 83. Pfizer Recent Development
  • Table 84. Johnson and Johnson Company Details
  • Table 85. Johnson and Johnson Business Overview
  • Table 86. Johnson and Johnson Orally Disintegrating Tablet Product
  • Table 87. Johnson and Johnson Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 88. Johnson and Johnson Recent Development
  • Table 89. GSK Company Details
  • Table 90. GSK Business Overview
  • Table 91. GSK Orally Disintegrating Tablet Product
  • Table 92. GSK Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 93. GSK Recent Development
  • Table 94. Otsuka Company Details
  • Table 95. Otsuka Business Overview
  • Table 96. Otsuka Orally Disintegrating Tablet Product
  • Table 97. Otsuka Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 98. Otsuka Recent Development
  • Table 99. Eli Lilly and Company Company Details
  • Table 100. Eli Lilly and Company Business Overview
  • Table 101. Eli Lilly and Company Orally Disintegrating Tablet Product
  • Table 102. Eli Lilly and Company Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 103. Eli Lilly and Company Recent Development
  • Table 104. AstraZeneca Company Details
  • Table 105. AstraZeneca Business Overview
  • Table 106. AstraZeneca Orally Disintegrating Tablet Product
  • Table 107. AstraZeneca Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 108. AstraZeneca Recent Development
  • Table 109. Bristol-Myers Squibb Company Details
  • Table 110. Bristol-Myers Squibb Business Overview
  • Table 111. Bristol-Myers Squibb Orally Disintegrating Tablet Product
  • Table 112. Bristol-Myers Squibb Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 113. Bristol-Myers Squibb Recent Development
  • Table 114. Conquer Company Details
  • Table 115. Conquer Business Overview
  • Table 116. Conquer Orally Disintegrating Tablet Product
  • Table 117. Conquer Revenue in Orally Disintegrating Tablet Business (2018-2023) & (US$ Million)
  • Table 118. Conquer Recent Development
  • Table 119. Research Programs/Design for This Report
  • Table 120. Key Data Information from Secondary Sources
  • Table 121. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Orally Disintegrating Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Orally Disintegrating Tablet Market Share by Type: 2022 VS 2029
  • Figure 3. Anti-Psychotics Drug Features
  • Figure 4. Anti-Epileptics Drug Features
  • Figure 5. Others Features
  • Figure 6. Global Orally Disintegrating Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Orally Disintegrating Tablet Market Share by Application: 2022 VS 2029
  • Figure 8. Hospital Case Studies
  • Figure 9. Retail Pharmacy Case Studies
  • Figure 10. Others Case Studies
  • Figure 11. Orally Disintegrating Tablet Report Years Considered
  • Figure 12. Global Orally Disintegrating Tablet Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 13. Global Orally Disintegrating Tablet Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 14. Global Orally Disintegrating Tablet Market Share by Region: 2022 VS 2029
  • Figure 15. Global Orally Disintegrating Tablet Market Share by Players in 2022
  • Figure 16. Global Top Orally Disintegrating Tablet Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet as of 2022)
  • Figure 17. The Top 10 and 5 Players Market Share by Orally Disintegrating Tablet Revenue in 2022
  • Figure 18. North America Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 19. North America Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • Figure 20. North America Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • Figure 21. North America Orally Disintegrating Tablet Market Share by Country (2018-2029)
  • Figure 22. United States Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Canada Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Europe Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • Figure 26. Europe Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • Figure 27. Europe Orally Disintegrating Tablet Market Share by Country (2018-2029)
  • Figure 28. Germany Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. France Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. U.K. Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Italy Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Russia Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. China Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. China Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • Figure 35. China Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • Figure 36. Asia Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 37. Asia Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • Figure 38. Asia Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • Figure 39. Asia Orally Disintegrating Tablet Market Share by Region (2018-2029)
  • Figure 40. Japan Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. South Korea Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. Southeast Asia Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. India Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Australia Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • Figure 47. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • Figure 48. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Share by Country (2018-2029)
  • Figure 49. Brazil Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 50. Mexico Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 51. Turkey Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Saudi Arabia Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Israel Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. GCC Countries Orally Disintegrating Tablet Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Teva Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 56. Merck Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 57. Mylan Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 58. Pfizer Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 59. Johnson and Johnson Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 60. GSK Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 61. Otsuka Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 62. Eli Lilly and Company Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 63. AstraZeneca Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 65. Conquer Revenue Growth Rate in Orally Disintegrating Tablet Business (2018-2023)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed
目次

Market Analysis and Insights:

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Orally Disintegrating Tablet estimated at US$ xx million in the year 2023, is projected to reach a revised size of US$ xx million by 2029, growing at a CAGR of xx % during the forecast period 2023-2029.

The US & Canada market for Orally Disintegrating Tablet is estimated to increase from $ xx million in 2023 to reach $ xx million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

The China market for Orally Disintegrating Tablet is estimated to increase from $ xx million in 2023 to reach $ xx million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

The Europe market for Orally Disintegrating Tablet is estimated to increase from $ xx million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

The global key companies of Orally Disintegrating Tablet include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, and AstraZeneca, etc. In 2022, the global top five players had a share approximately xx % in terms of revenue.

Report Includes:

This report presents an overview of global market for Orally Disintegrating Tablet market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Orally Disintegrating Tablet, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Orally Disintegrating Tablet, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Orally Disintegrating Tabletrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Orally Disintegrating Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Orally Disintegrating Tablet revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, and AstraZeneca, etc.

By Company

  • Teva
  • Merck
  • Mylan
  • Pfizer
  • Johnson and Johnson
  • GSK
  • Otsuka
  • Eli Lilly and Company
  • AstraZeneca
  • Bristol-Myers Squibb
  • Conquer

Segment by Type

  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Orally Disintegrating Tablet in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Orally Disintegrating Tablet companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orally Disintegrating Tabletrevenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1. Report Overview

  • 1.1. Study Scope
  • 1.2. Market Analysis by Type
    • 1.2.1. Global Orally Disintegrating Tablet Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2. Anti-Psychotics Drug
    • 1.2.3. Anti-Epileptics Drug
    • 1.2.4. Others
  • 1.3. Market by Application
    • 1.3.1. Global Orally Disintegrating Tablet Market Share by Application: 2018 VS 2022 VS 2029
    • 1.3.2. Hospital
    • 1.3.3. Retail Pharmacy
    • 1.3.4. Others
  • 1.4. Assumptions and Limitations
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Orally Disintegrating Tablet Market Perspective (2018-2029)
  • 2.2. Global Orally Disintegrating Tablet Growth Trends by Region
    • 2.2.1. Global Orally Disintegrating Tablet Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2. Orally Disintegrating Tablet Historic Market Size by Region (2018-2023)
    • 2.2.3. Orally Disintegrating Tablet Forecasted Market Size by Region (2024-2029)
  • 2.3. Orally Disintegrating Tablet Market Dynamics
    • 2.3.1. Orally Disintegrating Tablet Industry Trends
    • 2.3.2. Orally Disintegrating Tablet Market Drivers
    • 2.3.3. Orally Disintegrating Tablet Market Challenges
    • 2.3.4. Orally Disintegrating Tablet Market Restraints

3. Competition Landscape by Key Players

  • 3.1. Global Revenue Orally Disintegrating Tablet by Players
    • 3.1.1. Global Orally Disintegrating Tablet Revenue by Players (2018-2023)
    • 3.1.2. Global Orally Disintegrating Tablet Revenue Market Share by Players (2018-2023)
  • 3.2. Global Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3. Global Key Players of Orally Disintegrating Tablet, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4. Global Orally Disintegrating Tablet Market Concentration Ratio
    • 3.4.1. Global Orally Disintegrating Tablet Market Concentration Ratio (CR5 and HHI)
    • 3.4.2. Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Revenue in 2022
  • 3.5. Global Key Players of Orally Disintegrating Tablet Head office and Area Served
  • 3.6. Global Key Players of Orally Disintegrating Tablet, Product and Application
  • 3.7. Global Key Players of Orally Disintegrating Tablet, Date of Enter into This Industry
  • 3.8. Mergers & Acquisitions, Expansion Plans

4. Orally Disintegrating Tablet Breakdown Data by Type

  • 4.1. Global Orally Disintegrating Tablet Historic Market Size by Type (2018-2023)
  • 4.2. Global Orally Disintegrating Tablet Forecasted Market Size by Type (2024-2029)

5. Orally Disintegrating Tablet Breakdown Data by Application

  • 5.1. Global Orally Disintegrating Tablet Historic Market Size by Application (2018-2023)
  • 5.2. Global Orally Disintegrating Tablet Forecasted Market Size by Application (2024-2029)

6. North America

  • 6.1. North America Orally Disintegrating Tablet Market Size (2018-2029)
  • 6.2. North America Orally Disintegrating Tablet Market Size by Type
    • 6.2.1. North America Orally Disintegrating Tablet Market Size by Type (2018-2023)
    • 6.2.2. North America Orally Disintegrating Tablet Market Size by Type (2024-2029)
    • 6.2.3. North America Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • 6.3. North America Orally Disintegrating Tablet Market Size by Application
    • 6.3.1. North America Orally Disintegrating Tablet Market Size by Application (2018-2023)
    • 6.3.2. North America Orally Disintegrating Tablet Market Size by Application (2024-2029)
    • 6.3.3. North America Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • 6.4. North America Orally Disintegrating Tablet Market Size by Country
    • 6.4.1. North America Orally Disintegrating Tablet Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2. North America Orally Disintegrating Tablet Market Size by Country (2018-2023)
    • 6.4.3. North America Orally Disintegrating Tablet Market Share by Country (2024-2029)
    • 6.4.4. United States
    • 6.4.5. Canada

7. Europe

  • 7.1. Europe Orally Disintegrating Tablet Market Size (2018-2029)
  • 7.2. Europe Orally Disintegrating Tablet Market Size by Type
    • 7.2.1. Europe Orally Disintegrating Tablet Market Size by Type (2018-2023)
    • 7.2.2. Europe Orally Disintegrating Tablet Market Size by Type (2024-2029)
    • 7.2.3. Europe Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • 7.3. Europe Orally Disintegrating Tablet Market Size by Application
    • 7.3.1. Europe Orally Disintegrating Tablet Market Size by Application (2018-2023)
    • 7.3.2. Europe Orally Disintegrating Tablet Market Size by Application (2024-2029)
    • 7.3.3. Europe Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • 7.4. Europe Orally Disintegrating Tablet Market Size by Country
    • 7.4.1. Europe Orally Disintegrating Tablet Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2. Europe Orally Disintegrating Tablet Market Size by Country (2018-2023)
    • 7.4.3. Europe Orally Disintegrating Tablet Market Size by Country (2024-2029)
    • 7.4.4. Germany
    • 7.4.5. France
    • 7.4.6. U.K.
    • 7.4.7. Italy
    • 7.4.8. Russia
    • 7.4.9. Nordic Countries

8. China

  • 8.1. China Orally Disintegrating Tablet Market Size (2018-2029)
  • 8.2. China Orally Disintegrating Tablet Market Size by Type
    • 8.2.1. China Orally Disintegrating Tablet Market Size by Type (2018-2023)
    • 8.2.2. China Orally Disintegrating Tablet Market Size by Type (2024-2029)
    • 8.2.3. China Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • 8.3. China Orally Disintegrating Tablet Market Size by Application
    • 8.3.1. China Orally Disintegrating Tablet Market Size by Application (2018-2023)
    • 8.3.2. China Orally Disintegrating Tablet Market Size by Application (2024-2029)
    • 8.3.3. China Orally Disintegrating Tablet Market Share by Application (2018-2029)

9. Asia (excluding China)

  • 9.1. Asia Orally Disintegrating Tablet Market Size (2018-2029)
  • 9.2. Asia Orally Disintegrating Tablet Market Size by Type
    • 9.2.1. Asia Orally Disintegrating Tablet Market Size by Type (2018-2023)
    • 9.2.2. Asia Orally Disintegrating Tablet Market Size by Type (2024-2029)
    • 9.2.3. Asia Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • 9.3. Asia Orally Disintegrating Tablet Market Size by Application
    • 9.3.1. Asia Orally Disintegrating Tablet Market Size by Application (2018-2023)
    • 9.3.2. Asia Orally Disintegrating Tablet Market Size by Application (2024-2029)
    • 9.3.3. Asia Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • 9.4. Asia Orally Disintegrating Tablet Market Size by Region
    • 9.4.1. Asia Orally Disintegrating Tablet Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2. Asia Orally Disintegrating Tablet Market Size by Region (2018-2023)
    • 9.4.3. Asia Orally Disintegrating Tablet Market Size by Region (2024-2029)
    • 9.4.4. Japan
    • 9.4.5. South Korea
    • 9.4.6. China Taiwan
    • 9.4.7. Southeast Asia
    • 9.4.8. India
    • 9.4.9. Australia

10. Middle East, Africa, and Latin America

  • 10.1. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size (2018-2029)
  • 10.2. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Type
    • 10.2.1. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Type (2018-2023)
    • 10.2.2. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Type (2024-2029)
    • 10.2.3. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Share by Type (2018-2029)
  • 10.3. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Application
    • 10.3.1. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Application (2018-2023)
    • 10.3.2. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Application (2024-2029)
    • 10.3.3. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Share by Application (2018-2029)
  • 10.4. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Country
    • 10.4.1. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Country (2018-2023)
    • 10.4.3. Middle East, Africa, and Latin America Orally Disintegrating Tablet Market Size by Country (2024-2029)
    • 10.4.4. Brazil
    • 10.4.5. Mexico
    • 10.4.6. Turkey
    • 10.4.7. Saudi Arabia
    • 10.4.8. Israel
    • 10.4.9. GCC Countries

11. Key Players Profiles

  • 11.1. Teva
    • 11.1.1. Teva Company Details
    • 11.1.2. Teva Business Overview
    • 11.1.3. Teva Orally Disintegrating Tablet Introduction
    • 11.1.4. Teva Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.1.5. Teva Recent Development
  • 11.2. Merck
    • 11.2.1. Merck Company Details
    • 11.2.2. Merck Business Overview
    • 11.2.3. Merck Orally Disintegrating Tablet Introduction
    • 11.2.4. Merck Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.2.5. Merck Recent Development
  • 11.3. Mylan
    • 11.3.1. Mylan Company Details
    • 11.3.2. Mylan Business Overview
    • 11.3.3. Mylan Orally Disintegrating Tablet Introduction
    • 11.3.4. Mylan Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.3.5. Mylan Recent Development
  • 11.4. Pfizer
    • 11.4.1. Pfizer Company Details
    • 11.4.2. Pfizer Business Overview
    • 11.4.3. Pfizer Orally Disintegrating Tablet Introduction
    • 11.4.4. Pfizer Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.4.5. Pfizer Recent Development
  • 11.5. Johnson and Johnson
    • 11.5.1. Johnson and Johnson Company Details
    • 11.5.2. Johnson and Johnson Business Overview
    • 11.5.3. Johnson and Johnson Orally Disintegrating Tablet Introduction
    • 11.5.4. Johnson and Johnson Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.5.5. Johnson and Johnson Recent Development
  • 11.6. GSK
    • 11.6.1. GSK Company Details
    • 11.6.2. GSK Business Overview
    • 11.6.3. GSK Orally Disintegrating Tablet Introduction
    • 11.6.4. GSK Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.6.5. GSK Recent Development
  • 11.7. Otsuka
    • 11.7.1. Otsuka Company Details
    • 11.7.2. Otsuka Business Overview
    • 11.7.3. Otsuka Orally Disintegrating Tablet Introduction
    • 11.7.4. Otsuka Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.7.5. Otsuka Recent Development
  • 11.8. Eli Lilly and Company
    • 11.8.1. Eli Lilly and Company Company Details
    • 11.8.2. Eli Lilly and Company Business Overview
    • 11.8.3. Eli Lilly and Company Orally Disintegrating Tablet Introduction
    • 11.8.4. Eli Lilly and Company Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.8.5. Eli Lilly and Company Recent Development
  • 11.9. AstraZeneca
    • 11.9.1. AstraZeneca Company Details
    • 11.9.2. AstraZeneca Business Overview
    • 11.9.3. AstraZeneca Orally Disintegrating Tablet Introduction
    • 11.9.4. AstraZeneca Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.9.5. AstraZeneca Recent Development
  • 11.10. Bristol-Myers Squibb
    • 11.10.1. Bristol-Myers Squibb Company Details
    • 11.10.2. Bristol-Myers Squibb Business Overview
    • 11.10.3. Bristol-Myers Squibb Orally Disintegrating Tablet Introduction
    • 11.10.4. Bristol-Myers Squibb Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.10.5. Bristol-Myers Squibb Recent Development
  • 11.11. Conquer
    • 11.11.1. Conquer Company Details
    • 11.11.2. Conquer Business Overview
    • 11.11.3. Conquer Orally Disintegrating Tablet Introduction
    • 11.11.4. Conquer Revenue in Orally Disintegrating Tablet Business (2018-2023)
    • 11.11.5. Conquer Recent Development

12. Analyst's Viewpoints/Conclusions

13. Appendix

  • 13.1. Research Methodology
    • 13.1.1. Methodology/Research Approach
    • 13.1.2. Data Source
  • 13.2. Disclaimer
  • 13.3. Author Details